Loading...
Ramsay Health Care Limited
RMSYF•PNK
Healthcare
Medical - Care Facilities
$25.18
$-0.07(-0.28%)
Ramsay Health Care Limited (RMSYF) Financial Performance & Statements
Review Ramsay Health Care Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
12.13%
↑ 12.13%
Operating Income Growth
41.89%
↑ 41.89%
Net Income Growth
198.12%
↑ 198.12%
Operating Cash Flow Growth
1.75%
↑ 1.75%
Operating Margin
8.92%
↑ 8.92%
Gross Margin
10.90%
↑ 10.90%
Net Profit Margin
5.33%
↑ 5.33%
ROE
18.26%
↑ 18.26%
ROIC
8.90%
↑ 8.90%
Ramsay Health Care Limited (RMSYF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Ramsay Health Care Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $8.58B | $8.09B | $7.87B | $4.14B |
| Cost of Revenue | $7.74B | $7.32B | $7.16B | $3.41B |
| Gross Profit | $838.90M | $771.80M | $709.60M | $728.60M |
| Gross Profit Ratio | $0.10 | $0.10 | $0.09 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $344.20M | $329.60M | $322.50M | $0.00 |
| Operating Expenses | $344.20M | $329.60M | $322.50M | $527.30M |
| Total Costs & Expenses | $8.08B | $7.65B | $7.48B | $3.94B |
| Interest Income | $2.90M | $4.10M | $16.60M | $125.80M |
| Interest Expense | $306.40M | $313.60M | $279.80M | $0.00 |
| Depreciation & Amortization | $550.90M | $531.20M | $523.90M | $122.45M |
| EBITDA | $1.05B | $1.05B | $911.00M | $616.45M |
| EBITDA Ratio | $0.12 | $0.12 | $0.12 | $0.15 |
| Operating Income | $494.70M | $442.20M | $387.10M | $494.00M |
| Operating Income Ratio | $0.06 | $0.05 | $0.05 | $0.12 |
| Other Income/Expenses (Net) | -$312.90M | -$239.40M | -$186.60M | -$653.10M |
| Income Before Tax | $181.80M | $202.80M | $200.50M | $75.50M |
| Income Before Tax Ratio | $0.02 | $0.03 | $0.03 | $0.02 |
| Income Tax Expense | $54.00M | $67.30M | $79.50M | $26.10M |
| Net Income | $130.20M | $758.50M | $103.70M | $46.00M |
| Net Income Ratio | $0.02 | $0.09 | $0.01 | $0.01 |
| EPS | $0.53 | $3.29 | $0.42 | $0.20 |
| Diluted EPS | $0.53 | $3.28 | $0.42 | $0.20 |
| Weighted Avg Shares Outstanding | $228.80M | $228.30M | $228.10M | $227.95M |
| Weighted Avg Shares Outstanding (Diluted) | $229.52M | $228.80M | $228.79M | $228.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan